2005

Jul 22, 2005
Guidant Updates Corrective Actions Regarding Its VENTAK PRIZM AVT, VITALITY AVT, and CONTAK RENEWAL AVT Implantable Cardiac Defibrillators

Guidant Updates Corrective Actions Regarding Its VENTAK PRIZM AVT, VITALITY AVT, and CONTAK RENEWAL AVT Implantable Cardiac Defibrillators Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said...

Jul 21, 2005
Guidant Reports All-Time Record Sales of $974 Million

Worldwide implantable defibrillator revenue of $470 million, up 3 percent Worldwide coronary stent revenue of $118 million, down 2 percent Worldwide revenue from emerging businesses of $97...

Jul 20, 2005
Guidant Wins Decision in Heart Failure Device Patent Case

District Court for Delaware Upholds Validity of Mirowski Patent Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it won a key decision in a heart failure device patent...

Jul 18, 2005
Guidant Initiates Worldwide Physician Communications Regarding Important Safety Information and Corrective Action about Certain Pacemakers

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant apprised FDA of this...

Jul 6, 2005
Guidant Begins Enrollment in European Drug Eluting Stent Study

Data From Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...

Show 5102550100 per page
Top